FORM 2 - Corporate Substantial Shareholder Notice
 
Form Serial Number: CS20201022E00274 
1. Date of relevant event: 09/10/2020
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01952
4. Name of listed corporation: Everest Medicines Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 283,690,389
7. Name of substantial shareholder: C-Bridge Healthcare Fund IV, L.P. 
8. Registered office: Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands
9. Principal place of business in Hong Kong: Suites 3306-3307, Two Exchange Square, 8 Connaught Place, Central, Hong Kong 
15. Exchange on which listed:
16. Name of listed parent and exchange on which parent is listed:  
17. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
2201Interest of corporation controlled by you
53,639,823
Short position 
 
 
 
           
18. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
   
19. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position53,639,82318.91
20. Capacity in which interests disclosed in Box 19 are held:
Capacity codeNumber of shares
2201Interest of corporation controlled by you
Long position53,639,823

21. Further information in respect of derivative interests:
Derivatives codeNumber of shares
  
22. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
C-Bridge IV Investment Two LimitedBritish Virgin IslandsC-Bridge Healthcare Fund IV, L.P.97.09Y
Long position38,362,045
C-Bridge IV Investment Nine LimitedBritish Virgin IslandsC-Bridge Healthcare Fund IV, L.P.100.00Y
Long position15,277,778

23. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
24. Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
  
25. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
26. Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act:
NamesAddressRelationship CodePercentage (%)
  
 
27. Supplementary information:
28. Log/Serial Number of the previous form:
29. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 2: 22/10/2020
(dd/mm/yyyy)